Alzheimers research program support services for the congressionally directed medical research programs

Ended Awarded Last action

Contract number
HT942525F0232
Awardee
Awarding agency
Obligated
$168,589

Award facts

Opportunity
Contract value 100% obligated
$168,589.03 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 · Alzheimers research program $70,589
Supplemental Agreement for work within scope P00001 · Congressionally directed medical research program alzheimers RP to support transformative research on alzheimers disease/ad-related dementias with outcomes… $0
Original award $98,000

About this award

Leidos, Inc., through its Leidos Services Operating Segment Division (operating as SAIC), was awarded a $168,589 delivery order on June 1, 2025, to provide program support services for the Alzheimer's Research Program under the Congressionally Directed Medical Research Programs (CDMRP). This cost-plus-fixed-fee delivery order, with an ultimate completion date of May 31, 2026, will be performed in Frederick, Maryland. The award was issued by the Defense Health Agency, a component of the Department of Defense responsible for managing healthcare operations and medical research initiatives across the military health system. No set-aside designation was applied to this procurement, reflecting Leidos' competitive capabilities as an established large contractor.

The Congressionally Directed Medical Research Programs, administered by the Defense Health Agency and Naval Health Research Center, fund peer-reviewed medical research initiatives across multiple therapeutic areas mandated by Congress. The Alzheimer's Research Program represents a key component of CDMRP's focus on neurodegenerative diseases affecting military personnel and the broader population. Leidos brings substantial experience in medical research administration and support services through its existing $105.5 million contract with the Naval Health Research Center for research and development support and additional engagements across the defense health research portfolio, positioning it to effectively manage administrative and technical functions necessary to support the congressionally directed research initiative.

Quick answers

Who was awarded contract HT942525F0232?

HT942525F0232 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on June 1, 2025.

How much is contract HT942525F0232 worth?

The government has obligated $168,589 on HT942525F0232.

Is contract HT942525F0232 an order under another contract?

Yes. HT942525F0232 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942525F0232 competed?

The extent of competition for HT942525F0232 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award